📰 Applied News
Page 32 - Applied News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Applied. Real-time updates on events, politics, business and more.
February 15, 2022
The complete range of Telstar’s biological safety cabinets - Bio II Advance Plus and BiOptima - incorporates ZEROCOAT, a new antimicrobial bacteriological barrier, as a standard treatment applied in the work area. Click to read more...
February 8, 2022
MOUNT VERNON, NY / ACCESSWIRE / February 8, 2022 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), a pathogen elimination technology company that applies the power of narrow-range ultraviolet
February 3, 2022
Applied DNA Schedules Fiscal 2022 First Quarter Financial Results Conference Call and Webcast for Thursday, February 10, 2022 STONY BROOK, N.Y. -... | February 3, 2022
February 1, 2022
TAMPA, FL / ACCESSWIRE / February 1, 2022 / Applied Technology Academy, a military focused cyber training company, in partnership with Gier Productions, LLC will support a local screening of the lifechanging
January 28, 2022
St. Pölten UAS as Co-Founder of Entrepreneurship and Innovation Network for Smart and Sustainable European Regions (E.I.N.S.) The European University E³UDRES² coordinated by the St. Pölten
January 28, 2022
Jeddah: The visa procedure in Gulf countries is strict, and sticking to its rules to avoid infractions is always recommended, regardless of circumstances.
January 25, 2022
MOUNT VERNON, NY / ACCESSWIRE / January 25, 2022 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), a pathogen elimination technology company that applies the power of narrow-range ultraviolet
January 24, 2022
EQS-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Patent Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application
January 24, 2022
BEIJING and PHILADELPHIA, Jan. 24, 2022 /PRNewswire/ -- Applied Pharmaceutical Science, Inc. ("APS" or "the Company"), has recently announced the Investigational New Drug (IND) application for
January 18, 2022
Receives Patents for Pathogen Destroying Device in Hong Kong, ChinaAdds to Company's Portfolio of Patents for Disinfection Technology Addressing Global Challenge of Controlling the Spread of Emerging PathogensMOUNT